Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05795803
Other study ID # RC 11/2020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2020
Est. completion date May 31, 2020

Study information

Verified date March 2023
Source IRCCS Burlo Garofolo
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate whether a forced isolation context (such provided by the ongoing Covid-19 pandemic restrictive measures) could reduce the burden of somatic symptoms among a group of patients with Somatic Symptom Disorder (SSD). Secondary objective is to assess if a reduction in terms of depression tendency and anxiety occurs in this specific population and which are the effect of such a context among a group of adolescents without SSD. We want to compare these results with data obtained at the end of the pandemic.


Description:

This study aims to evaluate whether the forced isolation context provided by the ongoing Covid-19 pandemic is providing an advantage in terms of reduction of somatic symptoms burden among an Italian group of adolescents with SSD, assessed by the Patient Health Questionnaire (PhQ15) administered during and at the end of the pandemic. Secondary objectives of the study are: - To investigate the difference in anxiety and depression scores assessed by the Multidimensional Anxiety Scale for Children (MASC2) and Child Development Inventory (CDI-2) questionnaires among a group of SSD adolescents, during and after the pandemic isolation context. - To investigate the difference in anxiety and depression scores assessed by the Multidimensional Anxiety Scale for Children (MASC2) and Child Development Inventory (CDI-2) questionnaires among a group of adolescents without SSD, during and after the pandemic isolation context. - To compare the difference in anxiety and depression scores time modification between the two groups of adolescents. - To explore through tailored questions which adolescents' coping strategies are during a pandemic isolation context among SSD patients and a group of controls without SSD.


Recruitment information / eligibility

Status Completed
Enrollment 115
Est. completion date May 31, 2020
Est. primary completion date May 31, 2020
Accepts healthy volunteers No
Gender All
Age group 12 Years to 17 Years
Eligibility Inclusion Criteria: - Adolescents aged between 12 and 17 years old who received a diagnosis of SSD within the last six months or before unless assessed and confirmed by a specialist within the last six months - Adolescents without a diagnosis of SSD, who previously accessed the Institute for maternal and child health "Burlo Garofolo" Emergency Department for traumatic injuries or the Pediatric Clinic/Day Hospital Service for oral immunotherapy because of food allergies. - Adolescents experiencing a quarantine period during the Covid19 pandemic. Exclusion Criteria: - Adolescents with cognitive impairment. - Adolescents with chronic diseases. - Adolescents with other neuropsychiatric disorders according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorder (DSM V). - For the group without SSD diagnosis, any access to Emergency Department for unexplained chronic pain or any history of other psychiatric comorbidities.

Study Design


Intervention

Other:
Forced isolation context
Exposure to the forced isolation context provided by the ongoing Covid-19 pandemic restrictive measures

Locations

Country Name City State
Italy Institute for Maternal and Child Health - IRCCS Burlo Garofolo- Trieste

Sponsors (1)

Lead Sponsor Collaborator
IRCCS Burlo Garofolo

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in mean PhQ15 scale scores between T0 and T1 in the SSD adolescents group. To SSD group, the Health Questionnaire Physical Symptoms (PhQ15) will be administrated to quantify the somatic symptom burden. During the pandemic and within 6 months after the end
Secondary Difference in mean MASC2 scores between T0 and T1 in the SSD group. SSD adolescents will receive the Multidimensional Anxiety Scale for Children (MASC 2), composed by 50 items, to quantify adolescents' anxiety. During the pandemic and within 6 months after the end
Secondary Difference in mean CDI-2 short questionnaire scores between T0 and T1 in the SSD group. SSD adolescents will receive the Children's Depression Inventory (CDI-2) self-report short questionnaire, composed by 12 items, to quantify adolescents' depression. During the pandemic and within 6 months after the end
Secondary Difference in mean MASC2 scores between T0 and T1 in the adolescents group without SSD diagnosis. Adolescents without SSD will receive the Multidimensional Anxiety Scale for Children (MASC 2), composed by 50 items, to quantify adolescents' anxiety During the pandemic and within 6 months after the end
Secondary Difference in mean CDI-2 short questionnaires scores between T0 and T1 in the adolescents group without SSD diagnosis. Adolescents without SSD will receive the Children's Depression Inventory (CDI-2) self-report short questionnaire, composed by 12 items, to quantify adolescents' depression During the pandemic and within 6 months after the end
Secondary Comparison between the two groups of adolescents in the mean T1-T0 differences for MASC2 scores. Differences in the Multidimensional Anxiety Scale for Children (MASC 2), composed by 50 items During the pandemic and within 6 months after the end
Secondary Comparison between the two groups of adolescents in the mean T1-T0 differences for CDI-2 short questionnaires scores. Differences in Children's Depression Inventory (CDI-2) self-report short questionnaire, composed by 12 items During the pandemic and within 6 months after the end
Secondary Description of adolescents' coping strategies during a pandemic isolation context among SSD and non-SSD adolescent A general anonymous semi-structured survey will be administered to both the groups in order to investigate their habits, social media and videogames pattern of usage, and other leisure pattern of frequency. This will provide us a description of adolescents' general coping strategies during quarantine period. During the pandemic
See also
  Status Clinical Trial Phase
Completed NCT05446766 - Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety N/A
Completed NCT04122846 - Internet-based Emotional Awareness and Expression Therapy for Somatic Symptom Disorder N/A
Completed NCT04511286 - Exposure-Based Treatment for Undifferentiated Somatic Symptom Disorder N/A
Active, not recruiting NCT06149182 - Does the First Interview Matter: A Comparing Life Stress Interview Versus a Standard Psychiatric Intake Interview for Patients With Functional Somatic Disorder N/A
Completed NCT04664387 - Somatic Symptom Disorders in Patients With Myocardial Bridge
Completed NCT04044469 - Reappraisal Of Medical Assurance (ROMA): An Experimental Study in Patients With Functional Somatic Symptoms N/A
Completed NCT01966705 - Cognitive Behavior Therapy for Health Anxiety: A Comparison of Three Forms of Self-help N/A
Enrolling by invitation NCT03789084 - Hybrid Trial of Brief Cognitive-Behavioral Therapy for Health Anxiety in Primary Care N/A
Recruiting NCT05666921 - Alexithymia and Attachment Style in Patients With Somatic Symptoms
Recruiting NCT04835103 - Build a Research Clinic for Somatoform Patients N/A
Completed NCT03986125 - Student Anxiety & Stress Study N/A
Recruiting NCT05946512 - MR-spectroscopy in Post-covid Condition Prior to and Following a Yoga Breathing Intervention N/A
Recruiting NCT05792930 - Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder N/A
Recruiting NCT04899687 - Study of Dextromethorphan in OCD and Related Disorders Phase 2
Completed NCT05886361 - Somatic Symptoms in Autism Spectrum Disorder: Data Integration
Completed NCT02131883 - Outcome of Cognitive Behavioral Therapy for Patients With Severe Health Anxiety Treated in Group Only. A RCT. N/A
Completed NCT04751825 - Internet-based Emotional Awareness and Expression Therapy for Somatic Symptom Disorder - A Randomized Controlled Trial N/A
Completed NCT02314065 - Cognitive Behavioral Therapy for Health Anxiety: Internet Treatment Versus Face-to-Face Therapy N/A
Recruiting NCT06301360 - Internet Based Emotional Awareness and Expression Therapy for Functional Somatic Disorder With and Without Therapist Support N/A
Recruiting NCT05161819 - Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder N/A